New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
July 13, 2018 - The FDA announced the approval of SIGA Technologies’ TPOXX (tecovirimat), for the treatment of human smallpox disease caused by variola virus in adults and pediatric patients weighing at least 13 kg.
Download PDF
Return to publications